116 results on '"Koul, Hari K."'
Search Results
2. Tetrandrine for Targeting Therapy Resistance in Cancer
3. Phytochemicals for Human Health: The Emerging Trends and Prospects
4. Targeting ROS-Induced Epigenetic Reprograming in Cancer Stem Cells
5. Targeting ROS Induced Epigenetic Reprograming in Cancer Stem Cells
6. Regulation of SPDEF expression by DNA methylation in advanced prostate cancer
7. Abstract 1457: PDEF restricts prostate cancer cellular plasticity in part by modulating YAP1/TAZ-TEAD transcriptional network
8. Abstract A081: Epigenetic regulation of SPDEF gene in RCC7/T cells, a line of malignant African-American prostate epithelial cells
9. Editor's Note: p38 Mitogen-Activated Protein Kinase-Driven MAPKAPK2 Regulates Invasion of Bladder Cancer by Modulation of MMP-2 and MMP-9 Activity
10. Abstract 396: Therapeutic targeting of eukaryotic translation initiation factor 4 gamma 1 (EIF4G1) in enzalutamide resistant (ENZR) prostate cancer
11. Abstract 1471: Over-expression of WW domain containing transcription regulator 1 (TAZ/WWTR1) in prostate cancer and its modulation by prostate-derived ETS factor (PDEF)
12. Retraction Note: Hypoxia-associated p38 mitogen-activated protein kinase-mediated androgen receptor activation and increased HIF-1α levels contribute to emergence of an aggressive phenotype in prostate cancer
13. Retraction notice to “Differential effects of valproic acid on growth, proliferation and metastasis in HTB-5 and HTB-9 bladder cancer cell lines” [Canc. Lett. 281/2 (2009) 196–202]
14. Retraction Note to: Loss of PDEF, a prostate-derived Ets factor is associated with aggressive phenotype of prostate cancer: Regulation of MMP 9 by PDEF
15. Severe COVID-19 Is Characterized by an Impaired Type I Interferon Response and Elevated Levels of Arginase Producing Granulocytic Myeloid Derived Suppressor Cells
16. Hippo pathway: Regulation, deregulation and potential therapeutic targets in cancer
17. Pancreatic cancer: genetics, disease progression, therapeutic resistance and treatment strategies
18. MP79-13 EUKARYOTIC TRANSLATION INITIATION FACTOR 4 GAMMA 1 (EIF4G1) IS UPREGULATED IN ENZ RESISTANT PCA AND PLAYS AN IMPORTANT ROLE IN AGGRESSIVE PHENOTYPE
19. Prostate-Derived ETS Factor (PDEF) Modulates Yes Associated Protein 1 (YAP1) in Prostate Cancer Cells: A Potential Cross-Talk between PDEF and Hippo Signaling
20. Prostate-Derived ETS Factor (PDEF) Regulates Yes Associated Protein 1 (YAP1) in Prostate Cancer Cells: A Potential Cross-Talk between PDEF and Hippo Signaling
21. Eukaryotic Translation Initiation Factor 4 Gamma 1 (EIF4G1): a target for cancer therapeutic intervention?
22. Protocadherin 7 is overexpressed in castration resistant prostate cancer and promotes aberrant MEK and AKT signaling
23. The TLK1-Nek1 axis promotes prostate cancer progression
24. Abstract 1779: PCDH7 and SET are overexpressed in prostate cancer and promote aberrant MEK and AKT signaling
25. Abstract 3910: Tetrandrine inhibits signal transduction through PI3K/Akt/mTOR and PERK/eIF2á pathways to target aberrantly activated cap-dependent translation in cancer cells
26. Abstract 4385: Eukaryotic translation initiation factor 4 gamma 1 (EIF4G1): A target for cancer therapeutic intervention
27. Abstract 3063: Over expression of protein kinase Nek1 and its modulation by Thioridazine in prostate cancer
28. Abstract 3063: Over expression of protein kinase Nek1 and its modulation by Thioridazine in prostate cancer
29. Abstract 3910: Tetrandrine inhibits signal transduction through PI3K/Akt/mTOR and PERK/eIF2á pathways to target aberrantly activated cap-dependent translation in cancer cells
30. Abstract 5287: Prostate-derived Etsfactor modulates AR-mediated gene expression and promotes luminal differentiation
31. Abstract 5287: Prostate-derived Etsfactor modulates AR-mediated gene expression and promotes luminal differentiation
32. Abstract 4385: Eukaryotic translation initiation factor 4 gamma 1 (EIF4G1): A target for cancer therapeutic intervention
33. Abstract 1779: PCDH7 and SET are overexpressed in prostate cancer and promote aberrant MEK and AKT signaling
34. Reactive oxygen species and cancer: A complex interaction
35. Targeting the TLK1/NEK1 DDR axis with Thioridazine suppresses outgrowth of androgen independent prostate tumors
36. Prostate-Derived Ets Factor (PDEF) Inhibits Metastasis by Inducing Epithelial/Luminal Phenotype in Prostate Cancer Cells
37. Abstract 2821: Tousled like Kinase 1 binds to and regulates the protein kinase Nek1: Its implication in prostate cancer
38. Abstract 4305: TET increases p27Kip1 protein stability and p21WAF1/Cip1 promoter activity to block deregulated cell cycle progression in pancreatic cancer cells
39. Abstract 4436: Eukaryotic translation initiation factor 4 gamma 1 (EIF4G1) is upregulated modulates prostate cancer growth and proliferation
40. Abstract 1502: PDEF inhibits prostate cancer progression by promoting luminal differentiation
41. Tetrandrine inhibits deregulated cell cycle in pancreatic cancer cells: Differential regulation of p21 Cip1/Waf1 , p27 Kip1 and cyclin D1
42. Tetrandrine (TET) Induces Death Receptors Apo Trail R1 (DR4) and Apo Trail R2 (DR5) and Sensitizes Prostate Cancer Cells to TRAIL-Induced Apoptosis
43. Eukaryotic Translation Initiation Factor 4 Gamma 1 (eIF4G1) is upregulated during Prostate cancer progression and modulates cell growth and metastasis
44. Obituary for Donald S. Coffey: Remembering a pioneer in the field of prostate cancer research. (1932–2017)
45. Targeting the TLK1/NEK1 DDR Axis with THD Suppresses Outgrowth of Androgen Independent PCa Cells
46. Abstract 305: TET blocks cell cycle progression in pancreatic cancer cells at G1-S boundary by decreasing cyclin D1 and increasing CDK inhibitors (CKIs), p21 (WAF1, Cip1) and p27 (Kip1)
47. Abstract 2837: Differential expression of Protocadherin-7 (PCDH7) in prostate cancer (PCa) cells: a direct association between PCDH7 and castrate resistant PCa
48. Abstract 5061: TET inhibits prostate cancer tumor growth, progression and metastasis in TRAMP mice
49. Abstract 3525: PDEF promote prostate cancer luminal/epithelial differentiation and inhibit tumor progression
50. PDEF induce luminal differentiation in metastatic prostate cancer cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.